The bidder, which currently owns 89.27% of Pacific Smiles, has offered $2.20 in cash for each share in the company it doesn't already own, compared with the closing price on Thursday of $1.60.

Pacific Smiles has established an independent committee to assess the bid, and that committee has unanimously recommended that shareholders accept the offer in the absence of a superior bid.

The committee has also commissioned an independent expert's report into the bid, to assess whether it is fair and reasonable; however, the company said Deloitte Corporate Finance, which would produce the report, at this stage concluded that the bid was in the best interests of shareholders.

The independent board committee has carefully considered the offer to assess whether it is in the best interest of Pacific Smiles shareholders other than Genesis Bidco and its associates and, having completed that work, unanimously recommends that shareholders accept the offer.

The takeover offer is unconditional and is not subject to regulatory approval.

Takeover virtually a fait accompli

The company stated in its ASX announcement on Friday that a competing bid was highly unlikely, given the dominance of the majority shareholder and the fact that the next largest shareholder held a 10.01% stake in the company.

This meant the remaining shareholders own just 0.72% of Pacific Smiles.

The company in August reported an underlying profit of $11.8 million for FY25, up from $8.5 million the previous year, on revenue of $196 million, up 9.1%.

The company spent $11.6 million during the year responding to two previous takeover offers from Genesis Bidco and another vehicle, NDC Bidco, with the money allocated to legal fees and external consulting.

The earlier Genesis takeover offer was launched in July last year and offered $1.90 per share for the company, or a combination of cash and stock in the bidding company.

Pacific Smiles shareholders voted against the NDC proposal at a meeting held in August last year. NDC then walked away from the bidding process, and Genesis relaunched its offer and started building up its stake in the company.

Pacific Smiles shares are thinly traded, with an average trade volume of about 1500 shares.

The company was valued at $258.6 million at the close of trade on Thursday.

The post Dental group receives takeover bid at a handy premium appeared first on The Motley Fool Australia.

Although dividend season on the ASX is in a bit of a lull right now, that doesn't mean various shares on the All Ordinaries (ASX: XAO) Index aren't still paying out their latest dividends and thus have ex-dividend dates coming up.

Next week, there aren't too many blue chip ASX 200 stocks that have 'ex-div' dates scheduled. But we still have eight prominent All Ords stocks that will cut off eligibility for their next payouts for new investors.

Remember, when a share trades ex-dividend, it draws a line in the sand that divides eligible investors from non-eligible investors as to who gets the dividend in question.

It's usually only investors who own shares as of the market close on the last trading day before the ex-dividend date that receive the dividend paycheque. If you buy the shares on or after the ex-dividend date, you'll miss out and leave the rights to the dividend payment with the seller.

Because of this loss of value for new investors, it's typical to see a stock experience a drop in share price when the market opens on its ex-dividend date, reflecting the cash leaving the company.

With all that in mind, here are eight ASX All Ords shares that will undergo this process next week.

Eight ASX All Ords shares trading ex-dividend next week

*Dividend yield as of yesterday's market close

So not a whole lot of 'big' ASX names there. But even so, many investors hold at least one of these ASX All Ords shares, and so will be expecting a payout over the next month or two.

Remember, if you want the payouts from Pacific Smiles or Genesis Energy, you must own the shares before the end of today's trading.

The post 8 ASX All Ords shares with ex-dividend dates next week appeared first on The Motley Fool Australia.

Investors have been bidding the fund manager's shares higher after it received a takeover offer from Regal Partners Ltd (ASX: RPL).

But it isn't the only ASX share that is rising because of a takeover approach today. Two more shares that are shooting higher are listed below. Here's what they have announced:

Bigtincan Holdings Ltd (ASX: BTH)

The Bigtincan share price is up 33% to 16 cents. This has been driven by news that the sales enablement software provider has received a revised non-binding proposal from Vector Capital Management.

According to the release, Vector Capital Management has made an offer of $0.20 per share to acquire the company.

Bigtincan advised that the takeover offer contains the following statement:

Having reviewed the publicly available FY2024 year-end financial results and now having identified lenders willing and able to provide Vector with the necessary debt financing, Vector has received investment committee approval to, and would be prepared to, consummate a take-private transaction for BTH at an increased price of A$0.20 per share. Our offer is unconditional, does not have a financing contingency and is subject only to legal due diligence and entering into binding long form documents.

The ASX share's board advised that it will now evaluate the revised proposal with input from external advisors. It also warned that there is no certainty any control transaction will eventuate.

Vector Capital Management previously had a 19 cents per share offer rejected.

Pacific Smiles Group Ltd (ASX: PSQ)

The Pacific Smiles share price is up 16% to $1.86. This follows news that Beam Dental Bid Co, an associate of Genesis Capital, has tabled an offer for the dentist network.

According to the release, Genesis Capital proposes to acquire 100% of the shares in Pacific Smiles by way of an off-market takeover bid for $1.90 per share. This is in cash, scrip, or a mix of cash and scrip.

Pacific Smiles has advised that the offer will need to be considered in detail by its board and advisers before a formal recommendation is made to shareholders. It will also take into account feedback from shareholders and the likelihood of success of the offer when making its decision.

But as the offer, which is subject to conditions, is expected to open in the coming weeks and remain open for at least one month, it advised that there is no urgency to take action at this time.

In the meantime, it advised its shareholders to take no action in relation to the offer or any documents they may receive from Genesis Capital.

The post 2 OTHER ASX shares rocketing on takeover offers today appeared first on The Motley Fool Australia.

At the smaller end of town, two healthcare players have come in with solid results on Wednesday. These are Pacific Smiles Group Ltd (ASX: PSQ) and SomnoMed Ltd (ASX: SOM).

Both stocks are now in the green after their annual numbers. Let's take a look at what they posted.

ASX healthcare shares post FY24 numbers

Pacific Smiles reported a strong performance for FY24, with patient fees rising 7.9% to $291.8 million.

The ASX healthcare share's revenue grew by 8.7% to around $180 million, while earnings before interest, tax, depreciation and amortisation (EBITDA) surged by 17% over the year.

The company also repaid all borrowings during the year, ending the period debt-free and with $17.7 million in net cash.

This prompted the Board to declare a final fully franked dividend of 3.25 cents per share, bringing the total payout to 5.35 cents.

CEO Andrew Vidler expressed satisfaction with the company's performance:

We are exceptionally pleased with this year's result, which is a real testament to the team's commitment. Our focus on the utilisation of existing centres and to drive growth in patient fees has underpinned this performance.

Utilisation has improved across the business, especially among our newer cohorts. Our revenue growth and ongoing efficiency improvements drove margin improvement, offsetting the impact of inflationary cost pressures.

Looking ahead, Pacific Smiles remains focused on extending the benefits of its service model to more dentists and patients across Australia.

This performance also underscores the increasing importance patients place on preventive dental care and long-term oral health management. As more individuals commit to routine examinations, timely treatments, and structured care plans, practices are able to strengthen both clinical outcomes and operational stability.

Consistency in service delivery, efficient use of facilities, and a clear patient-focused approach remain critical drivers of sustainable growth. Desert Springs Dental Care las vegas illustrates how disciplined operations combined with strong patient engagement can support improved access to quality dentistry while maintaining financial resilience.

By continuing to align clinical excellence with efficient service models, the sector is well positioned to expand its reach and elevate oral health standards across communities.

The ASX healthcare share's FY25 performance is off to a strong start. Patient fees were up 10.9% year over year as of late August, totalling $50 million.

SomnoMed posts steady growth

SomnoMed also delivered a positive performance for FY24, with revenues reaching $91 million, up 9.6% from the previous year.

Despite this, gross margins tightened 300 basis points year over year to 69%. Whereas EBITDA came in line with expectations at $0.6 million.

Sales in its North American market were up 9% on the prior year, driven by "productivity optimisation, with record revenues in Q4…".

Meanwhile, in Europe, revenues were up nearly 11% at $52 million.

SomnoMed also incurred one-off restructuring costs of $3 million, which are expected to yield annualised savings of $5 million from the first quarter of FY25.

The ASX healthcare share's global patient base now exceeds 910,000, demonstrating its broad reach and impact in the sleep apnea treatment market.

Looking forward to FY25, SomnoMed has set ambitious targets, aiming for revenue of approximately $100 million and EBITDA of more than $5 million.

And it's already off to a decent start, according to the company:

Trading in the first 8 weeks of FY25 has seen revenue up approximately 20% year on year, on the back of the reduction of backlog and strong sales results. There is an expectation that growth will slow in the remaining quarters as the backlog is cleared. We have factored these dynamics into the FY25 guidance.

ASX healthcare shares snapshot

Investors in these ASX healthcare shares will likely be smiling after the companies produced reasonably strong FY24 earnings results.

In the last 12 months, Pacific Smiles shares are up 33%, whereas SonoMed shares have slipped 32% into the red.

The post 2 small ASX healthcare shares sprouting green after FY24 results appeared first on The Motley Fool Australia.

Four ASX shares that are rising more than most today are listed below. Here's why they are climbing:

Boss Energy Ltd (ASX: BOE)

The Boss Energy share price is up 8% to $4.74. This follows the release of the uranium producer's quarterly update this morning. That update revealed that the company's ramp-up to a steady-state production rate of 2.45Mlb of U3O8 per annum is now underway at the Honeymoon project following its successful commissioning. This saw the company produce its first drum of uranium after the quarter's end. Another positive is that the Honeymoon project is exceeding feasibility study forecasts. Management notes that this is being underpinned by the new processing technology adopted by Boss, which is central to the project's operating and financial success.

Pacific Smiles Group Ltd (ASX: PSQ)

The Pacific Smiles share price is up 16.5% to $1.90. Investors have been buying the dental company's shares after it received and accepted a new takeover offer. Pacific Smiles has entered into a scheme implementation deed with NDC HoldCo. It operates the National Dental Care centres and is a portfolio company managed by Crescent Capital Partners Management. A cash offer of $1.90 per share has been accepted. This is higher than a recent $1.75 per share from Genesis Capital. However, with its shares now trading in line with the NDC offer, it seems that some investors may be expecting an improved offer from Genesis Capital.

Perpetual Ltd (ASX: PPT)

The Perpetual share price is up 3% to $23.96. This morning, this fund manager responded to media speculation relating to a potential transaction. Perpetual confirmed that it has entered into exclusive talks with Kohlberg Kravis Roberts & Co (KKR) in relation to the potential acquisition of its Corporate Trust and Wealth Management businesses. However, it warned that there is no certainty of reaching a binding agreement or that any transaction would proceed. Perpetual intends to continue to keep the market informed in line with its continuous disclosure obligations.

ResMed Inc. (ASX: RMD)

The ResMed share price is up a further 3.5% to $32.57. Investors have been buying this sleep disorder treatment company's shares again on Monday following a very strong gain on Friday night for its NYSE listed shares. They rose 18% in response to the release of its third-quarter update. ResMed reported a 7% increase in revenue to US$1.2 billion, a 25% jump in income from operations to US$374.6 million, and a 29% lift in diluted earnings per share to US$2.04 per share.

The post Why Boss Energy, Pacific Smiles, Perpetual, and ResMed shares are racing higher appeared first on The Motley Fool Australia.

In morning trade, the ASX All Ords stock is up 15% to a 52-week high of $1.87.

Why is this ASX All Ords stock rocketing?

Investors have been buying the dental company's shares this morning after it received and accepted a new takeover offer.

As a reminder, Pacific Smiles has previously received bids of $1.40 per share and $1.75 per share from Genesis Capital.

According to the release, Pacific Smiles has entered into a scheme implementation deed (SID) with NDC HoldCo. It operates the National Dental Care centres and is a portfolio company managed by Crescent Capital Partners Management.

Under the terms of the deed, NDC agrees to acquire 100% of the shares in Pacific Smiles by way of scheme of arrangement for a cash consideration of $1.90 cash per share. This is subject to all applicable conditions being satisfied or waived.

The ASX All Ords stock will have the option to pay shareholders a fully franked dividend of up to a maximum of 12 cents per share before the deal completes. However, the cash consideration of the offer will be reduced by the amount of any such dividend.

Unanimously recommended

The Pacific Smiles board unanimously recommends shareholders vote in favour of the scheme at the scheme meeting. This is subject to no superior proposal emerging and the independent expert's report. All directors intend to vote in favour of the scheme under the same qualifications.

They highlight that NDC's offer represents a 59% premium to the undisturbed closing price of $1.20 per share on 15 December 2023. That was the last trading day prior to the announcement that Genesis Capital had made an offer.

Furthermore, the board notes that the offer under the scheme represents an enterprise value multiple on the mid-point of FY 2024 EBITDA guidance of ~11x and an equity value of $303 million based on its outstanding shares.

The scheme remains conditional upon a number of items, including shareholder and FIRB approval. If everything goes to plan, the ASX All Ords stock expected the scheme to be implemented in August.

However, if it doesn't then shareholders will be penalised. The release notes that if FIRB approval is delayed beyond 27 September, a ticking fee of one cent per share per month will accrue after each full calendar month until approval is obtained.

Following today's gain, this ASX All Ords stock is up 35% since this time last year.

The post Why this ASX All Ords stock is sparkling 15% brighter today appeared first on The Motley Fool Australia.

As we head into the Monday lunch hour, the All Ordinaries is just about flat, having recovered from an earlier intraday loss of 0.5%.

But this ASX All Ords share is up 18.0%, trading for $1.41 per share.

Any guesses?

If you said dental centre operator Pacific Smiles Group Ltd (ASX: PSQ), give yourself a virtual gold star.

Here's what's lifting the Pacific Smiles share price today.

ASX All Ords share in takeover crosshairs

The Pacific Smiles share price is soaring after the company reported it has received an unsolicited, non-binding proposal from Genesis Capital regarding a potential acquisition.

Genesis Capital's proposal is for $1.40 in cash per Pacific Smiles share via a recommended scheme of arrangement. That's almost 18% above where the ASX All Ords share closed on Friday at $1.195 per share.

According to the release, Genesis Capital is also considering options that would allow Pacific Smiles shareholders the opportunity to roll their shares into unlisted equity.

Genesis Capital has acquired 29.9 million Pacific Smiles shares, representing 18.75% of the dental centre operator's issued capital.

Pacific Smiles board said it considers the indicative proposal to be "opportunistically timed".

The board said it "will act in what it considers to be the best interests of Pacific Smiles and its shareholders as a whole".

The board of the ASX All Ords share said that included assessing the takeover proposal "relative to continuing to capitalise on our existing network, brand and current trading momentum, and further leveraging our organic growth capability and strong balance sheet position".

Management stressed there was no certainty the proposal would result in a transaction. Shareholders do not need to take any action at this time.

Pacific Smiles has appointed Greenhill & Co as financial adviser and Gilbert + Tobin as legal adviser.

Pacific Smiles share price snapshot

Today's big lift sees the Pacific Smiles share price up 22% over the past month.

The ASX All Ords share remains down 9% year to date.

The post Guess which ASX All Ords share just rocketed 18% on takeover news appeared first on The Motley Fool Australia.

As earnings season continues, the S&P/ASX 200 Health Care Index (ASX: XHJ) is down 0.087%, while the S&P/ASX All Ordinaries Index (ASX: XAO) is up 0.34%.

Let's review these results.

4 ASX healthcare shares ripping up the charts today

Starpharma Holdings Ltd (ASX: SPL)

ASX healthcare share Starpharma rose to an intraday high of 16 cents, up 14.3%, after the ASX biotech company released its preliminary full-year FY23 results. Starpharma revealed a 14% decline in revenue to $4.2M and a reported loss of $15.6 million, which was a 3% improvement on FY22. The company said its loss was due to research and product development expenses of $11.239 million.

Telix Pharmaceuticals Ltd (ASX: TLX)

ASX healthcare share Telix Pharmaceuticals is also rising high today, up 10.8% at its intraday peak of $10.85. The radiation therapy biotech released its half-year FY23 results today. Telix reported revenue of $220.8 million, up from just $24 million in 1H FY22. The company said the revenue surge was largely due to growing sales of its prostate cancer imaging agent, Illuccix, which was launched in the United States in April 2022. At the bottom line was a net loss after tax of $14.3 million.

Pacific Smiles Group Ltd (ASX: PSQ)

Pacific Smiles shares rose to an intraday high of $1.37, up 8.7%, after the dental services network released its full-year FY23 results. Group revenue came in at $165.3 million, up 18.5% on FY22. Underlying earnings before interest, taxes, depreciation, and amortisation (EBITDA) was $24.1 million, up 113.9%. The underlying net profit after tax (NPAT) was $4.5 million, up from a net loss of $3.2 million in FY22. The ASX healthcare share will pay a fully franked final dividend of 2.27 cents per share (cps). The total annual dividend is 2.62 cps, representing a payout ratio of 100% of underlying NPAT.

SDI Ltd (ASX: SDI)

SDI shares rose to an intraday high of 89 cents, up 4.7%, after the dental materials developer and manufacturer revealed record sales of $107.9 million in its full-year FY23 report. Sales went up 13.3% on FY22, and EBITDA increased by 9.6% to $16.2 million. The product margin improved by 100 basis points to 56.8% following price increases and some lower logistics costs. Earnings per share (EPS) was down 19 cents to 5.94 cps. The ASX healthcare share will pay a fully franked final dividend of 1.75 cps.

The post 4 ASX healthcare shares charging higher on positive earnings updates appeared first on The Motley Fool Australia.

That's according to leading brokers, who've just upgraded their outlook for the five stocks, all of which operate in distinctly different sectors (courtesy of The Australian).

These ASX All Ords shares just got an upgrade

Up first, we have Aristocrat Leisure Limited (ASX: ALL).

CLSA raised the gaming technology company's stock to a 'buy' with a $44.90 price target.

The ASX All Ords share is up 0.8% in intraday trading today at $38.53. That implies a potential further upside of 16.5% for the stock.

With a strong growth outlook for its digital gaming businesses, the Aristocrat Leisure share price has soared 25% year to date.

The second ASX All Ords share receiving a broker upgrade is Pacific Smiles Group Limited (ASX: PSQ).

Wilsons boosted the dental centre operator's stock to an 'overweight' rating with a $1.66 price target.

The Pacific Smiles share price is up 2.6% at the time of writing, at $1.55 per share. That implies a potential 7% gain ahead yet from here.

Despite a positive earnings growth outlook, the Pacific Smiles share price is flat in 2023.

Also getting a broker upgrade this week is PWR Holdings (ASX: PWH).

Evans & Partners lifted its rating for the automotive cooling solutions company's stock to 'positive'. Shares are up 2.3% in early afternoon trade today, at $9.02 apiece.

With some potential earnings growth ahead, this ASX All Ords share may yet be able to shake off its 18% year-to-date losses.

Rounding off the list of broker upgrades

Rounding off the list, the fourth stock that's just received a broker upgrade is Smartpay Holdings Limited (ASX: SMP)

Bell Potter started the payment solutions provider's stock at a 'buy' with a $2.16 price target.

The Smartpay share price is down 1.9% today at $1.75 a share. That implies a potential 23.4% upside for this ASX All Ords share.

This will come as welcome news to shareholders, who've already enjoyed a 74% lift in the Smartpay share price in 2023. And the stock is up a whopping 186% over 12 months.

Which brings us to the fifth company getting a broker upgrade this week, Transurban Group (ASX: TCL).

Citi has raised its rating on the toll road operator and developer's stock to a 'buy' with a $16.20 price target.

Transurban shares are down 0.3% today, trading for $14.07 apiece. That implies a potential upside of 15.1% for this ASX All Ords share.

The Transurban share price is up 10% in 2023.

The post 5 ASX All Ords shares just upgraded by top brokers appeared first on The Motley Fool Australia.

After all, even when high inflation or rising interest rates eat into spending power, consumers still want to take care of their physical and mental well-being.

According to LSN Capital Partners director Nick Sladen, there are also longer-term demographic forces at play.

"The healthcare industry has always been an attractive sector for investors given its defensive earnings stream that has compounded over the long term," Sladen told Livewire.

"The structural tailwinds from an [ageing] population that is spending an increasing amount on their health needs is a key driver of this earnings growth."

This structural growth, unfortunately, took a pause during the COVID-19 era, as even private health resources were diverted to fight the pandemic.

But now that the world is well and truly in the post-COVID epoch, it could be a case of everything old is new again.

"Looking ahead… we believe that current operating conditions will prove to be cyclical in nature, and we expect to see a return to long-term growth levels in the period ahead," said Sladen.

"Demand is further supported by the pandemic-related backlogs that require more intensive medical services as a result of late diagnosis of chronic illness."

So here are the three ASX shares from the health sector that Sladen's team loves right now:

Three 'compelling investment opportunities'

Sladen is particularly interested in the federal government's anti-inflation initiative to allow annual fee indexation in excess of 3.6% for certain health services.

"This covers most GP service items, and diagnostic [imaging] and will provide a revenue uplift for participants from the 1st of July 2023," he said.

"Given this favourable backdrop, we see some compelling investment opportunities in the healthcare space."

This leads to his first two picks.

"Capitol Health Ltd (ASX: CAJ) and Integral Diagnostics Ltd (ASX: IDX) are diagnostic imaging companies that are well positioned for a return to more normalised trading conditions."

Capitol Health, with branches in suburban Melbourne, commands about a 4% market share in the diagnostic imaging sector, according to Sladen.

"Over the past three years, it has successfully rolled out nine greenfield sites (three per year), integrated two major transactions and executed well on a cost-out program," he said.

"With a return to more normalised operating conditions, the company is on the cusp of delivering earnings growth in excess of 50% over the next two years and yet trades at a discount to historical averages."

The Capitol share price is down 17.7% over the past 12 months, while paying out a 3.6% dividend yield.

The imaging industry is hot for takeover activity too, Sladen noted, citing last year's acquisition of PRP Diagnostic by a consortium of private equity and superannuation funds.

The LSN Capital team's third pick is dental centre operator Pacific Smiles Group Ltd (ASX: PSQ).

According to Sladen, the company is set for "significant earnings growth".

"[The stock] is trading at a valuation that does not reflect the earnings momentum, strategic nature of the assets and growth opportunities ahead," he said.

"The group recently reported strong revenue trends (+17% pcp) from improving attendance levels and average spend per visit, which has had a positive impact on profitability for the 2H23."

Pacific Smiles shares have plunged 22% over the past year.

The post 'Highly sought-after': 3 ASX healthcare shares ready to roar again appeared first on The Motley Fool Australia.

In a memo to clients, the team at QVG Capital Long Short Fund named three such stocks that have rocketed in recent times, which it is still backing for further gains:

'High energy, entrepreneurial culture'

Mader Group Ltd (ASX: MAD) is an outsourcer for clients in the mining industry.

On the back of its latest numbers, the stock has soared an eye-opening 37% year to date.

"Their update showed revenues up 59% and was particularly pleasing given their March quarter is typically seasonally weak."

There are two reasons why the QVG analysts reckon Mader shares are set for further rises.

"Firstly, their customer is paying a discount to what an OEM would charge and only a small premium to what it would cost to do it 'in house'," read the memo.

"Considering the additional quality and flexibility this means good value for the customer."

The other tailwind is that, despite it now having a $1 billion market capitalisation, Mader has maintained a "high energy, entrepreneurial culture" first established by founder and chair Luke Mader.

"A highly incentivised and fast paced team is exactly what's required to expand successfully into new markets, as is Mader's strategy."

73% gain already this year

Dental centre network Pacific Smiles Group Ltd (ASX: PSQ) has seen its share price take off 28% over the past three weeks.

The QVG team noted that the company last month reaffirmed its earnings guidance.

"When people talk about stocks being cheap on a price-to-earnings or PE ratio, we remind ourselves this is only true if you use the right 'E'," read the memo.

"This update confirms that trading has improved and removes uncertainty around the 'E'." 

Mader and Pacific Smiles have done pretty well in 2023, but they are not even in the same ballpark as Duratec Ltd (ASX: DUR).

The share price for the infrastructure maintenance contractor has gained a spectacular 73% since the start of the year.

The QVG note mentioned that in April the company boosted its earnings guidance by 12%.

"The rate of contract wins, the performance of their recent acquisition WPF and the absence of problem projects underpins Duratec's guidance and outlook."

The conservative nature of the projects Duratec's management takes on is a big bonus for QVG analysts.

"We are only aware of a few problem projects in their history, which is testament to their internal controls and the nature of the jobs and customers they're willing to take on."

The post 'Revenues up 59%': 3 small-cap ASX shares rocketing right now (and set for more gains) appeared first on The Motley Fool Australia.

Most businesses have just reported their result for the period to December 2022, though a few have reporting periods that end in January.

With that in mind, let's look at four that go ex-dividend this week. When an ASX All Ordinaries share goes ex-dividend, it means that new investors are no longer entitled to that dividend. Investors need to buy shares before the ex-dividend date to get the dividend entitlement.

Supply Network Limited (ASX: SNL)

Supply Network trades in Australia and New Zealand under the Multispares brand. It sells trucks and business parts.

The business declared an interim dividend of 20 cents per share. This fully franked dividend comes with an ex-dividend date of 22 March 2023. That means investors only have today to grab shares before it goes ex-dividend.

The payment date for this dividend is 6 April 2023.

Pacific Smiles Group Ltd (ASX: PSQ)

Pacific describes itself as Australia's fastest-growing dentist service organisation, with over 120 dental centres nationally.

The All Ordinaries ASX share has started paying a dividend again, with an interim fully franked dividend declared of 0.35 cents per share.

Pacific Smiles will also have an ex-dividend date of 22 March 2023, so investors only have today to invest before Pacific Smiles shares go ex-dividend.

The business has a payment date of 6 April 2023.

Service Stream Ltd (ASX: SSM)

Service Stream describes itself as a provider of essential network services to the telecommunications, utility and transport sectors. It operates in all states and territories.

The business announced that it was going to pay an interim dividend of 0.5 cents per share, fully franked. Its ex-dividend date is 22 March 2023, which means investors have to buy shares today to be entitled to the dividend.

The ASX All Ordinaries share is going to pay this interim dividend on 6 April 2023.

Myer Holdings Ltd (ASX: MYR)

Myer is the department store business which is currently going through a bit of a revival.

It reported its result later than others, but its ex-dividend date is this week as well.

Myer announced that it's going to pay a total interim dividend of 8 cents per share, which included a special dividend of 4 cents per share.

The ex-dividend date for this ASX All Ordinaries share's dividend is 22 March 2023, so investors need to buy shares today to gain entitlement to this upcoming dividend.

The payment date for this dividend is 11 May 2023.

The post 4 ASX All Ordinaries shares trading ex-dividend on Wednesday appeared first on The Motley Fool Australia.